hydroxyurea and misonidazole

hydroxyurea has been researched along with misonidazole in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19902 (40.00)18.7374
1990's1 (20.00)18.2507
2000's1 (20.00)29.6817
2010's1 (20.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bundy, BN; Creasman, WT; Currie, JL; Keys, H; Mortel, R; Stehman, FB1
Allen, J; Edwards, MS; Levin, VA; Ortega, J; Vestnys, P; Wara, WM1
Bundy, BN; Creasman, WT; d'Ablaing, G; Fowler, WC; Keys, HM; Mortel, R; Stehman, FB; Thomas, G1
Anderson, LL; Donohue, KA; Heller, PB; Hernandez, E; Stehman, FB1
Ali, S; Lanciano, R; Rose, PG; Stehman, FB; Whitney, CW1

Trials

3 trial(s) available for hydroxyurea and misonidazole

ArticleYear
A randomized trial of hydroxyurea versus misonidazole adjunct to radiation therapy in carcinoma of the cervix. A preliminary report of a Gynecologic Oncology Group study.
    American journal of obstetrics and gynecology, 1988, Volume: 159, Issue:1

    Topics: Adenocarcinoma; Adult; Aged; Carcinoma, Squamous Cell; Clinical Trials as Topic; Combined Modality Therapy; Female; Humans; Hydroxyurea; Middle Aged; Misonidazole; Random Allocation; Uterine Cervical Neoplasms

1988
Hydroxyurea versus misonidazole with radiation in cervical carcinoma: long-term follow-up of a Gynecologic Oncology Group trial.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1993, Volume: 11, Issue:8

    Topics: Adult; Aged; Aged, 80 and over; Carcinoma; Cause of Death; Chemotherapy, Adjuvant; Female; Follow-Up Studies; Humans; Hydroxyurea; Life Tables; Middle Aged; Misonidazole; Recurrence; Survival Analysis; Uterine Cervical Neoplasms

1993
The significance of thrombocytosis in patients with locally advanced cervical carcinoma: a Gynecologic Oncology Group study.
    Gynecologic oncology, 2000, Volume: 78, Issue:2

    Topics: Adult; Aged; Antineoplastic Agents; Cohort Studies; Combined Modality Therapy; Disease-Free Survival; Female; Humans; Hydroxyurea; Incidence; Lymph Node Excision; Middle Aged; Misonidazole; Multicenter Studies as Topic; Neoplasm Recurrence, Local; Proportional Hazards Models; Radiation-Sensitizing Agents; Randomized Controlled Trials as Topic; Survival Analysis; Thrombocytosis; Uterine Cervical Neoplasms

2000

Other Studies

2 other study(ies) available for hydroxyurea and misonidazole

ArticleYear
5-Fluorouracil and 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) followed by hydroxyurea, misonidazole, and irradiation for brain stem gliomas: a pilot study of the Brain Tumor Research Center and the Childrens Cancer Group.
    Neurosurgery, 1984, Volume: 14, Issue:6

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Brain Neoplasms; Brain Stem; Child; Child, Preschool; Cobalt Radioisotopes; Combined Modality Therapy; Dose-Response Relationship, Radiation; Female; Fluorouracil; Glioblastoma; Glioma; Humans; Hydroxyurea; Lomustine; Male; Misonidazole; Prognosis; Radioisotope Teletherapy

1984
Outcome of stage IVA cervical cancer patients with disease limited to the pelvis in the era of chemoradiation: a Gynecologic Oncology Group study.
    Gynecologic oncology, 2011, Jun-01, Volume: 121, Issue:3

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Cisplatin; Combined Modality Therapy; Disease-Free Survival; Female; Fluorouracil; Humans; Hydroxyurea; Middle Aged; Misonidazole; Neoplasm Staging; Randomized Controlled Trials as Topic; Retrospective Studies; Survival Rate; Treatment Outcome; Uterine Cervical Neoplasms

2011
chemdatabank.com